These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 29172995)
1. PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma. Barkdull S; Brownell I Cancer Biol Ther; 2017 Dec; 18(12):937-939. PubMed ID: 29172995 [TBL] [Abstract][Full Text] [Related]
2. PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma. Gaiser MR; Bongiorno M; Brownell I Expert Rev Clin Pharmacol; 2018 Apr; 11(4):345-359. PubMed ID: 29478343 [TBL] [Abstract][Full Text] [Related]
3. Avelumab: a new standard for treating metastatic Merkel cell carcinoma. Baker M; Cordes L; Brownell I Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384 [TBL] [Abstract][Full Text] [Related]
4. Avelumab: A Novel Anti-PD-L1 Agent in the Treatment of Merkel Cell Carcinoma and Urothelial Cell Carcinoma. Teets A; Pham L; Tran EL; Hochmuth L; Deshmukh R Crit Rev Immunol; 2018; 38(3):159-206. PubMed ID: 30004857 [TBL] [Abstract][Full Text] [Related]
5. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805 [TBL] [Abstract][Full Text] [Related]
7. Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma. Joseph J; Zobniw C; Davis J; Anderson J; Trinh VA Ann Pharmacother; 2018 Sep; 52(9):928-935. PubMed ID: 29616562 [TBL] [Abstract][Full Text] [Related]
8. Avelumab and other recent advances in Merkel cell carcinoma. Bommareddy PK; Kaufman HL Future Oncol; 2017 Dec; 13(30):2771-2783. PubMed ID: 28976209 [TBL] [Abstract][Full Text] [Related]